Stakeholders provide feedback on FDA draft guidance on drug development for early Alzheimer's disease
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesClinical TrialsPharmaceuticalsUnited StatesRegulatory NewsFerdous Al-FaruqueBiologics/ biosimilars/ vaccinesClinical TrialsPharmaceuticalsUnited States